PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Stefan, N. ; Lonardo, A.* ; Targher, G.*

Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases.

Nat. Rev. Gastroenterol. Hepatol., DOI: 10.1038/s41575-023-00880-2 (2023)
Publ. Version/Full Text DOI PMC
Steatotic liver disease has emerged as an important risk factor for cardiovascular disease, type 2 diabetes mellitus and chronic kidney disease. Successful treatment of steatotic liver disease might also be effective in preventing these cardiometabolic diseases.
Altmetric
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Editorial
Language english
Publication Year 2023
HGF-reported in Year 2023
ISSN (print) / ISBN 1759-5045
e-ISSN 1759-5053
Journal Nature Reviews - Gastroenterology & Hepatology
Publisher Nature Publishing Group
Publishing Place Heidelberger Platz 3, Berlin, 14197, Germany
Reviewing status Peer reviewed
Institute(s) Institute of Diabetes Research and Metabolic Diseases (IDM)
POF-Topic(s) 90000 - German Center for Diabetes Research
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502400-001
DOI 10.1038/s41575-023-00880-2
WOS ID 001114647200001
Scopus ID 85178913335
PubMed ID 38057417
Erfassungsdatum 2023-12-11
[➜Report correction]